Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University | ClinicalTrials HQ

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
CD34+ (Non-Malignant) Stem Cell Selection for Patients Receiving Allogeneic Stem Cell Transplantation	AIDS, Blood-Borne Infections, Bone Marrow Failure Disorders, Congenital Bone Marrow Failure Syndromes, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Diamond-Blackfan anemia, Digestive System Diseases, Familial Hemophagocytic Lymphocytosis, Genital Diseases, HIV infectious disease, Hemic and Lymphatic Diseases, Histiocytosis, Langerhans-Cell, Infections, Kostmann syndrome, Lipid Metabolism Disorders, Lipid Metabolism, Inborn Errors, Lymphohistiocytosis, Hemophagocytic, Nutritional and Metabolic Diseases, Primary Immunodeficiency Diseases, RNA Virus Infections, Shwachman-Diamond syndrome, Slow Virus Diseases, Urogenital Diseases, anemia, aplastic anemia, bone marrow disorder, exocrine pancreatic insufficiency, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, histiocytosis, immune system disorder, immunoproliferative disorder, inborn error of immunity, infectious disease, inherited aplastic anemia, inherited hemoglobinopathy, interstitial lung disease, lentivirus infection, lipomatosis, lung disorder, lymphatic system disorder, lymphoproliferative syndrome, macrophage activation syndrome, metabolic disease, non-Langerhans cell histiocytosis, pancreas disorder, pure red-cell aplasia, respiratory system disorder, sexually transmitted disease, sickle cell disease, sickle cell-beta-thalassemia disease syndrome, uterine carcinosarcoma, viral infectious disease, viral sexually transmitted disease	Active, not recruiting	Phase 1 / Phase 2	2025-08-14		NCT01966367